Garbarg M - Search Results

1

Modulation of acetylcholine, capsaicin and substance P effects by histamine H3 receptors in isolated perfused rabbit lungs.

Delaunois A, Gustin P, Garbarg M, Ansay M. Delaunois A, et al. Among authors: garbarg m. Eur J Pharmacol. 1995 Apr 24;277(2-3):243-50. doi: 10.1016/0014-2999(95)00085-y. Eur J Pharmacol. 1995. PMID: 7493615

2

High affinity binding of 3H-histamine in rat brain.

Palacios JM, Schwartz JC, Garbarg M. Palacios JM, et al. Among authors: garbarg m. Eur J Pharmacol. 1978 Aug 15;50(4):443-4. doi: 10.1016/0014-2999(78)90151-6. Eur J Pharmacol. 1978. PMID: 699966 No abstract available.

3

Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor.

Arrang JM, Garbarg M, Schwartz JC. Arrang JM, et al. Among authors: garbarg m. Nature. 1983 Apr 28;302(5911):832-7. doi: 10.1038/302832a0. Nature. 1983. PMID: 6188956

4

N-ethylmaleimide-induced changes in agonist affinity for histamine H1-receptors in the guinea pig brain.

Yeramian E, Garbarg M, Schwartz JC. Yeramian E, et al. Among authors: garbarg m. Mol Pharmacol. 1985 Aug;28(2):155-62. Mol Pharmacol. 1985. PMID: 4022000

5

[125I]Iodobolpyramine, a highly sensitive probe for histamine H1-receptors in guinea-pig brain.

Korner M, Bouthenet ML, Ganellin CR, Garbarg M, Gros C, Ife RJ, Sales N, Schwartz JC. Korner M, et al. Among authors: garbarg m. Eur J Pharmacol. 1986 Jan 21;120(2):151-60. doi: 10.1016/0014-2999(86)90535-2. Eur J Pharmacol. 1986. PMID: 3948916

6

Actions of betahistine at histamine receptors in the brain.

Arrang JM, Garbarg M, Quach TT, Dam Trung TuongM, Yeramian E, Schwartz JC. Arrang JM, et al. Among authors: garbarg m. Eur J Pharmacol. 1985 Apr 23;111(1):73-84. doi: 10.1016/0014-2999(85)90115-3. Eur J Pharmacol. 1985. PMID: 2990946

7

Synergism between histamine H1- and H2-receptors in the cAMP response in guinea pig brain slices: effects of phorbol esters and calcium.

Garbarg M, Schwartz JC. Garbarg M, et al. Mol Pharmacol. 1988 Jan;33(1):38-43. Mol Pharmacol. 1988. PMID: 2826997

8

Structure-activity studies with histamine H3-receptor ligands.

Ganellin CR, Fkyerat A, Hosseini SK, Khalaf YS, Piripitsi A, Tertiuk W, Arrang JM, Garbarg M, Ligneau X, Schwartz JC. Ganellin CR, et al. Among authors: garbarg m. J Pharm Belg. 1995 Mar-Jun;50(2-3):179-87. J Pharm Belg. 1995. PMID: 7674117 Review.

9

Bioavailability, antinociceptive and antiinflammatory properties of BP 2-94, a histamine H3 receptor agonist prodrug.

Rouleau A, Garbarg M, Ligneau X, Mantion C, Lavie P, Advenier C, Lecomte JM, Krause M, Stark H, Schunack W, Schwartz JC. Rouleau A, et al. Among authors: garbarg m. J Pharmacol Exp Ther. 1997 Jun;281(3):1085-94. J Pharmacol Exp Ther. 1997. PMID: 9190840

10

Novel chiral H3-receptor agonists.

Lipp R, Arrang JM, Buschmann J, Garbarg M, Luger P, Schunack W, Schwartz JC. Lipp R, et al. Among authors: garbarg m. Agents Actions Suppl. 1991;33:277-82. doi: 10.1007/978-3-0348-7309-3_18. Agents Actions Suppl. 1991. PMID: 1711275

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results